NCT03704545已完成不适用
Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home
Centre Hospitalier Universitaire de Nīmes2 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2019年1月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 174
- 试验地点
- 2
- 主要终点
- Number of exacerbation events
研究概览
简要总结
The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return of the patient to his home.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The patient has signed the consent form.
- •The patient is affiliated to a health insurance programme
- •The patient is at least 18 years old (≥).
- •The patient is admitted to complete hospitalization (for patients in the "Hospital and Control" groups).
- •The patient is diagnosed with stage 2 to 4 Chronic Obstructive Pulmonary Disease. The diagnosis as well as the stage of the disease are validated by a pulmonologist at the facility.
- •The patient has one or more inhaler devices to treat Chronic Obstructive Pulmonary Disease.
- •The patient returns to his / her home when discharged from hospital (for patients in the "Hospital and Control" groups).
- •The patient is available for a follow-up of 12 months.
排除标准
- •The subject participates in another interventional study.
- •The subject is in an exclusion period determined by a previous study.
- •The patient is under safeguard of justice.
- •The subject refuses to sign the consent.
- •It is not possible to give the patient (or his/her trusted-person) informed information.
结局指标
主要结局
Number of exacerbation events
时间窗: Month 12
Exacerbation events will be defined as any episode of increased respiratory symptoms, especially dyspnea, cough and sputum production, and increased sputum purulence.
次要结局
- Medication Possession Ratio(12 months)
- Number of visits to the attending physician(Month 12)
- device usage learning curve(12 months)
- Number of hospitalisation events(Month 12)
- Usability score of devices(Month 12)
- satisfaction questionnaire(Month 12)
- Number of visits to the pulmonologist(Month 12)
- Number of visits to the hospital emergency service(Month 12)
- Quality of life questionnaire(Month 12)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Pharmaceutical Consultation at Hospital Discharge and Adherence to Anti-infective TreatmentInfectionNCT02126930Centre Hospitalier Universitaire de Nīmes174
撤回
不适用
Pharmaceutical Consultation and Exchange Between the Pharmacy and the HospitalDiabetesNCT04811183Hospices Civils de Lyon100
尚未招募
不适用
PCAD (Pharmaceutical Consultation At Discharge)Drug related problems (medicijn gerelateerde problemen)NL-OMON25210/A720
Unknown
不适用
Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse EventsOral Anticancer Therapy.NCT02733965Assistance Publique Hopitaux De Marseille190
已完成
不适用
Effect of Pharmacist Provided Drug Information Services After Hospital DischargeDrug CounselingNCT03829995Region Hovedstadens Apotek250